Caesalpinia spinosa
Botanicalexperimental
Tara spinosa, commonly known as tara (Quechua), also known as Peruvian carob or spiny holdback, is a small leguminous tree or thorny shrub native to Peru. T. spinosa is cultivated as a source of tannins based on a galloylated quinic acid structure. This chemical structure has been confirmed also by LC–MS. It is also grown as an ornamental plant because of its large colorful flowers and pods. — Wikipedia
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Oct 31, 2018 (NCT03663881)
Timeline
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaTara spinosa ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05007444 | Phase 2 | Oct 1, 2021 | Hospital Universitario San Ignacio, Pontificia Universidad Javeriana |
| NCT04410510 | Phase 2/Phase 3 (Phase 3) | Jun 30, 2020 | Hospital Universitario San Ignacio, Pontificia Universidad Javeriana |
| NCT03663881 | Phase 1 | Oct 31, 2018 | Hospital Universitario San Ignacio, Pontificia Universidad Javeriana |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Hospital Universitario San Ignacio | Academic/Hospital | 3 | 3 | 3 | 2018 |
| Pontificia Universidad Javeriana | Academic/Hospital | 3 | 0 | 3 | 2018 |
2 organizations
Page 1 / 1